Hongning Zhou Selected Research

Infections

2/2022	Seroepidemiologic study on convalescent sera from dengue fever patients in Jinghong, Yunnan.
1/2019	A Gut Commensal Bacterium Promotes Mosquito Permissiveness to Arboviruses.
1/2018	Salivary factor LTRIN from Aedes aegypti facilitates the transmission of Zika virus by interfering with the lymphotoxin-β receptor.
1/2013	Anti-folate combination therapies and their effect on the development of drug resistance in Plasmodium vivax.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongning Zhou Research Topics

Disease

4	Malaria 05/2022 - 02/2016
4	Infections 02/2022 - 01/2013
3	Melanoma (Melanoma, Malignant) 04/2009 - 06/2007
2	Dengue (Dengue Fever) 02/2022 - 01/2020
2	Japanese Encephalitis 11/2020 - 06/2019
2	Neoplasms (Cancer) 11/2013 - 10/2003
2	Genomic Instability 01/2012 - 06/2011
1	Severe Dengue 02/2022
1	Coinfection 02/2022
1	Parasitic Diseases (Parasitic Disease) 02/2019
1	Carcinogenesis 01/2011
1	Influenza in Birds (Avian Flu) 02/2010
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2009
1	Skin Neoplasms (Skin Cancer) 06/2007

Drug/Important Bio-Agent (IBA)

2	Neutralizing AntibodiesIBA 02/2022 - 11/2020
2	artemisinin (artemisinine)IBA 01/2021 - 02/2016
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2008
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 03/2008
2	CytokinesIBA 01/2018 - 01/2011
2	NF-kappa B (NF-kB)IBA 04/2009 - 03/2008
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 04/2009 - 06/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2009 - 06/2007
2	LigandsIBA 04/2009 - 06/2007
2	arseniteIBA 03/2008 - 06/2007
2	sodium arsenite (sodium metaarsenite)IBA 03/2008 - 06/2007
1	InsecticidesIBA 05/2022
1	AntibodiesIBA 02/2022
1	Dengue VaccinesIBA 02/2022
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	Pyrimethamine (Daraprim)FDA Link 01/2021
1	Antimalarials (Antimalarial Agents)IBA 01/2021
1	DNA VaccinesIBA 01/2020
1	VaccinesIBA 06/2019
1	Bile Pigments (Bilin)IBA 02/2019
1	Indicators and Reagents (Reagents)IBA 02/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	MucinsIBA 01/2019
1	Environmental CarcinogensIBA 11/2013
1	Drug CombinationsIBA 01/2013
1	Biological ProductsIBA 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 06/2011
1	Hemagglutinins (Hemagglutinin)IBA 02/2010
1	Neuraminidase (Sialidase)IBA 02/2010
1	Ataxia Telangiectasia Mutated ProteinsIBA 04/2009
1	Phosphotransferases (Kinase)IBA 04/2009
1	Small Interfering RNA (siRNA)IBA 04/2009
1	2- morpholin- 4- yl- 6- thianthren- 1- yl- pyran- 4- oneIBA 04/2009
1	ResveratrolIBA 03/2008
1	Death Domain ReceptorsIBA 03/2008
1	Fas Ligand Protein (Fas Ligand)IBA 06/2007
1	Keratins (Keratin)IBA 10/2003

Therapy/Procedure

1	Mass Drug Administration 05/2022